Asia Pacific Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Disease Indication (Multiple Sclerosis, Parkinson's Disease, Alzheimer's Disease, Others), By Drug Type (Immunomodulator, Vesicular Monoamine Transporter 2 (VMAT2), Others), By Routes of Administration (Oral, Intravenous (IV) delivery, Others) and By Country (China, Korea, Japan, India, Australia, Taiwan, South East Asia, Rest of Asia-Pacific) Forecasts, 2026-2034

List of Tables

Table 1: APAC Asia Pacific Neurodegenerative Disease Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 2: APAC Asia Pacific Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 3: APAC Asia Pacific Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 4: APAC Asia Pacific Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 5: China Asia Pacific Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 6: China Asia Pacific Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 7: China Asia Pacific Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 8: Korea Asia Pacific Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 9: Korea Asia Pacific Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 10: Korea Asia Pacific Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 11: Japan Asia Pacific Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 12: Japan Asia Pacific Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 13: Japan Asia Pacific Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 14: India Asia Pacific Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 15: India Asia Pacific Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 16: India Asia Pacific Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 17: Australia Asia Pacific Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 18: Australia Asia Pacific Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 19: Australia Asia Pacific Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 20: Taiwan Asia Pacific Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 21: Taiwan Asia Pacific Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 22: Taiwan Asia Pacific Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 23: South East Asia Asia Pacific Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 24: South East Asia Asia Pacific Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 25: South East Asia Asia Pacific Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)

Table 26: Rest of Asia-Pacific Asia Pacific Neurodegenerative Disease Market Size and Forecast By Disease Indication - 2022-2034 (USD Billion)

Table 27: Rest of Asia-Pacific Asia Pacific Neurodegenerative Disease Market Size and Forecast By Drug Type - 2022-2034 (USD Billion)

Table 28: Rest of Asia-Pacific Asia Pacific Neurodegenerative Disease Market Size and Forecast By Routes of Administration - 2022-2034 (USD Billion)